Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-8


She Hopps worked as a bacteriologist at Garfield Memorial Hospital and then Walter Reed Army Institute of Research. Hopps She joined the National Institutes of Health (NIH) in 1956, first in the National Institute of Allergy and Infectious Diseases. She In 1960, she joined the NIH Division of Biologics Standards (DBS) in 1960 in the Laboratory of Viral Immunology. Hopps There she worked with Drs. Paul Parkman and Harry Meyer on the Rubella rubella vaccine and the patented Rubella rubella antibody test.

Hopps authored or co-authored more than 89 articles, was awarded two patents (her second was , including one for the BS-C-1 continuous cell line that she developed ), and was the national president of Graduate Women in Science. The BS-C-1 continuous cell line developed by Hopps was made from African green monkey kidney cells. The BS-C-1 continuous cell line is still used today and is suitable for propagating several viruses, including polio, measles, Rift Valley fever, respiratory syncytial, Coxsackie A9, O'Malley's A-1 agent, and simian agents 1, 4 and 5. Thanks to Hopps’ her work, the BS-C-1 continuous cell line provides the virologist with virologists another tool for diagnostic and research work and perhaps for the large-scale cultivation of viral agents for vaccines.

She was the national president of Graduate Women in Science.

Dive
classgrid-col-4

a professional photo of Hope Hopps in a plaid blouse

Span
classcaption

Portrait of Hope Hopps

Span
classcredit

Sigma Delta Epsilon records, #3605. Division of Rare and Manuscript Collections, Cornell University Library

Info

Hopps worked in Building 29A, second floor, beginning in 1967 when it opened, but likely worked in Building 29, second floor with the Laboratory of Viral Immunology before that.

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-6

Hopps also became an administrator after After the transfer of biologics from the NIH to the Food and Drug Administration (FDA) in 1972, Hopps also became an administrator,  first as the assistant to the Director of Biologics and then as acting Associate Director associate director for Program Development & and Operations, working in Building 29.

After retiring from government service, Hopps continued to work as a consultant and guest worker in the FDA’s Center for Drugs and Biologics (which would later be renamed the Center for Biologics Evaluation and Research [CBER], as it is still called today).

See also, “Finding Hope: A Woman’s Place Is In The Lab” Exhibition

Dive
classgrid-col-6

a photo of two men and one woman, Hope Hopps, in a lab, wearing white lab coats

Span
classcaption

Dr. Meyer at left, Hopps at center, and Dr. Parkman at right with the rubella vaccine

Span
classcredit

National Library of Medicine

...